Oncologic Outcomes of Nipple-sparing Mastectomy and Immediate Reconstruction After Neoadjuvant Chemotherapy for Breast Cancer
- 20 March 2020
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Annals of Surgery
- Vol. 274 (6), e1196-e1201
- https://doi.org/10.1097/sla.0000000000003798
Abstract
Objectives: To evaluate the oncologic outcomes and risk factors for locoregional recurrence (LRR) and nipple-areola complex recurrence (NR) in a large series of breast cancer patients who underwent nipple-sparing mastectomy (NSM) and immediate reconstruction after neoadjuvant chemotherapy (NACT). Summary of Background Data: The use of NSM and immediate reconstruction in breast cancer patients receiving NACT is increasing. However, the oncologic safety of this approach is unclear. Patients and Methods: A total of 310 breast cancer patients (319 breasts) who underwent NACT and NSM between February 2010 and November 2016 were retrospectively analyzed. Clinical and pathologic factors associated with increased risks of LRR and NR were analyzed using univariate (Chi-square or Fisher exact test) and multivariate (Cox proportional hazard regression model) analyses. Results: During a mean follow-up of 63 ± 22 months, 38 cases had LRR as the first event, including 6 cases of NR as the first event. The 5-year cumulative LRR and NR rates were 11.0% and 1.9%, respectively. In univariate analysis, clinical T stage, pathologic nodal status, histologic grade, lymphovascular invasion, and post-NACT Ki67 status were associated with increased LRR risk, and post-NACT Ki67 status was the only significant risk factor for NR. In multivariate analysis, post-NACT Ki67 ≥10% (hazard ratio, 4.245; 95% confidence interval, 1.865–9.663; P = 0.001) was an independent risk factor for LRR. Conclusions: NSM and immediate reconstruction seem to be oncologically safe with acceptable LRR and NR rates for appropriately selected breast cancer patients treated with NACT. Post-NACT Ki67 ≥10% was associated with increased risk of LRR or NR, and therefore, necessitates cautious follow-up.Keywords
This publication has 28 references indexed in Scilit:
- The oncological safety of nipple-sparing mastectomy – A Swedish matched cohort studyEuropean Journal of Surgical Oncology, 2014
- Nipple Skin-Sparing Mastectomy is Feasible for Advanced DiseaseAnnals of Surgical Oncology, 2013
- Clinical and radiological predictors of nipple-areola complex involvement in breast cancer patientsEuropean Journal of Cancer, 2012
- Conservative mastectomy: extending the idea of breast conservationThe Lancet Oncology, 2012
- Predictors of locoregional outcome in patients receiving neoadjuvant therapy and postmastectomy radiationCancer, 2012
- Optimising radiation treatment decisions for patients who receive neoadjuvant chemotherapy and mastectomyThe Lancet Oncology, 2012
- Risk factors associated with recurrence after nipple-sparing mastectomy for invasive and intraepithelial neoplasiaAnnals of Oncology, 2012
- Occult Nipple Involvement in Breast Cancer: Clinicopathologic Findings in 316 Consecutive Mastectomy SpecimensJournal of Clinical Oncology, 2009
- Nipple-sparing mastectomy: risk of nipple-areolar recurrences in a series of 579 casesBreast Cancer Research and Treatment, 2008
- Neoadjuvant Versus Adjuvant Systemic Treatment in Breast Cancer: A Meta-AnalysisJNCI Journal of the National Cancer Institute, 2005